Preserving access to treatment for patients with serious mental illnesses by prohibiting restrictions on drug dispensing.

Massachusetts H4892 aims to preserve access to treatment for patients with serious mental illnesses by prohibiting carriers and utilization review organizations from imposing prior authorization requirements, step therapy protocols, or any other protocols that could restrict or delay the dispensing of FDA-approved drugs for these conditions. The bill defines "serious mental illness" to include conditions such as bipolar disorders, major depressive disorders, obsessive-compulsive disorders, paranoid personality disorder, schizo-affective disorders, schizophrenia, and post-traumatic stress.

Preserving access to treatment for patients with serious mental illnesses by prohibiting restrictions on drug dispensing.

Massachusetts H4892 aims to preserve access to treatment for patients with serious mental illnesses by prohibiting carriers and utilization review organizations from imposing prior authorization requirements, step therapy protocols, or any other protocols that could restrict or delay the dispensing of FDA-approved drugs for these conditions. The bill defines "serious mental illness" to include conditions such as bipolar disorders, major depressive disorders, obsessive-compulsive disorders, paranoid personality disorder, schizo-affective disorders, schizophrenia, and post-traumatic stress.